Business executives may not know it, but they are wasting billions of their gross profits on ineffective, even harmful drugs in their health plans. That’s one implication of the study Joel Lexchin and I just published in the BMJ (formerly British Medical Journal).
Big Pharma’s Hidden Business Model and How Your Company Funds It
Why waste profits on ineffective, harmful drugs?
September 12, 2012